We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$9.78B
AUM Growth
+$239M
Cap. Flow
-$199M
Cap. Flow %
-2.04%
Top 10 Hldgs %
39.84%
Holding
1,386
New
76
Increased
471
Reduced
763
Closed
70

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.4M
2
ORCL icon
Oracle
ORCL
+$10.8M
3
AMZN icon
Amazon
AMZN
+$10.3M
4
COST icon
Costco
COST
+$7.38M
5
XOM icon
ExxonMobil
XOM
+$6.78M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$32.3M
2
ACN icon
Accenture
ACN
+$18.1M
3
ABBV icon
AbbVie
ABBV
+$14.4M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 37.1%
2 Consumer Discretionary 11.12%
3 Healthcare 10.76%
4 Financials 10.45%
5 Communication Services 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TMHC
726
DELISTED
Taylor Morrison
TMHC
$853K 0.01%
15,386
-1,076
-7% -$61.5K
MASI
727
DELISTED
Masimo
MASI
$850K 0.01%
6,748
-2,392
-26% -$315K
RIVN icon
728
Rivian
RIVN
$23.3B
$847K 0.01%
63,099
+8,352
+15% +$87.3K
BRBR icon
729
BellRing Brands
BRBR
$1.24B
$843K 0.01%
14,757
-4,135
-22% -$237K
GNTX icon
730
Gentex
GNTX
$4.78B
$839K 0.01%
24,902
-2,956
-11% -$102K
RPRX icon
731
Royalty Pharma
RPRX
$27.1B
$836K 0.01%
31,704
+606
+2% +$16.8K
RBC icon
732
RBC Bearings
RBC
$15.8B
$836K 0.01%
3,097
-323
-9% -$86.8K
GMED icon
733
Globus Medical
GMED
$11.1B
$827K 0.01%
12,071
-5,029
-29% -$300K
PARA
734
DELISTED
Paramount Global Class B
PARA
$825K 0.01%
79,406
-62
-0.1% -$726
CYTK icon
735
Cytokinetics
CYTK
$10B
$824K 0.01%
15,202
+1,348
+10% +$81.4K
GTLS
736
DELISTED
Chart Industries
GTLS
$824K 0.01%
5,706
-398
-7% -$60.1K
ARW icon
737
Arrow Electronics
ARW
$10.4B
$822K 0.01%
6,808
-470
-6% -$60.1K
FOX icon
738
Fox Class B
FOX
$25.8B
$820K 0.01%
25,610
-3,266
-11% -$98.7K
BWA icon
739
BorgWarner
BWA
$13.1B
$817K 0.01%
25,344
-11,700
-32% -$405K
SSD icon
740
Simpson Manufacturing
SSD
$7.46B
$817K 0.01%
4,845
-1,313
-21% -$230K
EVR icon
741
Evercore
EVR
$11.2B
$816K 0.01%
3,917
-391
-9% -$76.1K
AXTA icon
742
Axalta
AXTA
$7.92B
$813K 0.01%
23,788
-4,630
-16% -$158K
SNAP icon
743
Snap
SNAP
$9.18B
$812K 0.01%
48,909
-621
-1% -$8.91K
INGR icon
744
Ingredion
INGR
$6.6B
$811K 0.01%
7,072
-720
-9% -$83.1K
MUR icon
745
Murphy Oil
MUR
$5.11B
$810K 0.01%
19,648
-1,264
-6% -$55.1K
NOV icon
746
NOV
NOV
$7.48B
$809K 0.01%
42,548
-4,353
-9% -$81.6K
MTZ icon
747
MasTec
MTZ
$19.4B
$807K 0.01%
7,544
+268
+4% +$27.1K
GLOB icon
748
Globant
GLOB
$1.75B
$805K 0.01%
4,514
-787
-15% -$139K
WBS
749
DELISTED
Webster Financial
WBS
$803K 0.01%
18,430
-2,016
-10% -$89.8K
HLI icon
750
Houlihan Lokey
HLI
$9.3B
$801K 0.01%
5,937
-600
-9% -$78.5K
28 29
30
31 32

Similar funds

PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
BS
Banco Santander Madrid, Spain $16.1B AUM 35.02% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $16.1B AUM 40.83% 1-Year Est. Return
NMO
Newlands Management Operations Dallas, Texas $16.6B AUM 3.91% 1-Year Est. Return

Xponance's Q2 2024 Portfolio in Review

As of Q2 2024, Xponance held 1,386 positions worth $9.78B, up 2.5% from $9.54B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Xponance's Q2 2024 filing shows 76 new, 471 increased, 763 reduced and 70 closed positions. Its largest new stake was GE Vernova: 36,466 shares worth $6.25M. The largest sale was UnitedHealth, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q2 2024 buy was GE Vernova: 36,466 shares worth $6.25M.
  • Xponance added most to Merck in Q2 2024, an estimated $24.4M increase.
  • Xponance's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $32.3M.
  • Xponance fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $8.15M.
  • Xponance's ten largest holdings make up 40% of its $9.78B portfolio in Q2 2024.
  • Xponance opened 76 new positions and closed 70 in Q2 2024.
  • Xponance's portfolio value rose 2.5% quarter-over-quarter to $9.78B.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.